Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01181960 · ClinicalTrials.gov registry record
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
A clinical trial, sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 1,066
- Enrollment target
NCT01181960 is a clinical trial that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 1,066 participants.
The verdict
NCT01181960 has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 1,066 participants
- Enrollment target
Study Summary
The purpose of this study is to build a data repository that can be used to understand pharmaceutical utilization patterns among patients being treated in community behavioral health organizations (CBHOs) for schizophrenia or bipolar I disorder.
Interventions
- DRUG Risperidone long acting injectable - New Starts
- DRUG Risperidone long acting injectable - Continuous Users
- DRUG Paliperidone Palmitate -New and Continuous Users
- DRUG Other Antipsychotics - New Starts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,066 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01181960
The ClinicalTrials.gov registry entry for NCT01181960 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,066 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Scientific Affairs, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Risperidone long acting injectable - New Starts is the first listed.
NCT01181960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01181960 about?
NCT01181960 is a clinical study titled "Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations". The purpose of this study is to build a data repository that can be used to understand pharmaceutical utilization patterns among patients being treated in community behavioral health organizations (CBHOs) for schizophrenia or bipolar I disorder.
What is the current status of trial NCT01181960?
This trial is currently completed. The enrollment target is 1,066 participants. The study started on 2010-08. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01181960?
The interventions under investigation include: Risperidone long acting injectable - New Starts (DRUG), Risperidone long acting injectable - Continuous Users (DRUG), Paliperidone Palmitate -New and Continuous Users (DRUG), Other Antipsychotics - New Starts (DRUG).
Who is sponsoring clinical trial NCT01181960?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.